Free Trial
→ No. 1 stock to cash in on the death of iPhone (From Stansberry Research) (Ad)tc pixel
NASDAQ:INGN

Inogen Q3 2026 Earnings Date & Estimates

Inogen logo
$6.18 +0.24 (+4.04%)
Closing price 10/9/2026 04:00 PM Eastern
Extended Trading
$6.18 0.00 (0.00%)
As of 10/9/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Inogen is scheduled to report Q3 2026 earnings on Wednesday, November 4, 2026, before market opens. The conference call is scheduled for 8:30 AM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
Before Market Opens
Conference Call
8:30 AM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Inogen in Q3 2026

Inogen is expected to post earnings of -$0.11 per share on revenue of $92.23 million. In the same quarter a year earlier Inogen reported -$0.20 per share on revenue of $92.39 million. Inogen last reported on August 6, 2026, posting -$0.14 per share and beating the -$0.1533 consensus estimate. Inogen has beaten the consensus EPS estimate in 7 of its last 8 quarters.

Consensus Estimates

Consensus EPS
-$0.11
Expected Revenue
$92.23 million
Prior-Year EPS
-$0.20
Prior-Year Revenue
$92.39 million
Expected Revenue Growth
-0.2%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$0.14 (Beat by +$0.0133)
Last Quarter Revenue
$95.08 million
EPS Beat Rate
7 of last 8 quarters

Prepare for the Q3 2026 Call

Inogen Q3 2026 Earnings FAQ

Inogen (NASDAQ:INGN) is scheduled to report Q3 2026 earnings on Wednesday, November 4, 2026, before market opens.

Inogen's Q3 2026 earnings conference call is scheduled for Wednesday, November 4, 2026 at 8:30 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Inogen to post earnings of -$0.11 per share for Q3 2026.

The consensus revenue estimate for Inogen is $92.23 million for Q3 2026.

Inogen Earnings Headlines

Inogen (NASDAQ:INGN) Stock Price Breaks Above Fifty Day Moving Average - Should You Sell?
 |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31105068
Inogen: Selling Rental Is A Start, Continued Work To Be Done
October 1, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4951456-inogen-selling-rental-is-a-start-continued-work-to-be-done?utm_source=marketbeat.com&utm_medium=referral&feed_item_type=article?source=MarketBeat
No. 1 stock to cash in on the death of iPhone
Analyst Josh Baylin, who warned Congress about smartphones years before the iPhone launched, says the world's richest man may be building an iPhone rival he calls Starphone. Baylin points to FCC rulings, two trademarks filed the same day, multibillion-dollar spectrum deals, chip partnerships, and a string of posts from Elon Musk as evidence pointing to one conclusion. See the full research and the stock Baylin is watching now.tc pixel
October 10 at 1:00 AM  |  Stansberry Research (Ad)
Biggest stock movers Thursday: GOOG, INGN, and more
October 1, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4648880-biggest-stock-movers-thursday-goog-ingn-and-more
Inogen to Sell US Oxygen Rental Business to Rotech for Up to $25 Million
October 1, 2026  |  marketscreener.comM
Inogen Streamlines Operations With Major Asset Divestiture
September 30, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/inogen-streamlines-operations-with-major-asset-divestiture?utm_source=marketbeat.com&utm_medium=referral
See More Inogen Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Inogen? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Inogen and other key companies, straight to your email.

About Inogen

Inogen (NASDAQ:INGN). is a medical technology company that develops, manufactures and markets oxygen therapy products for people with chronic respiratory conditions. The company focuses primarily on oxygen concentrators, which extract oxygen from ambient air and deliver supplemental oxygen without requiring traditional compressed-gas or liquid-oxygen tanks.

Its product portfolio has included the Inogen One family of portable oxygen concentrators, designed to support mobility and independence, as well as stationary oxygen concentrators such as the Inogen At Home system. Products are marketed through direct-to-consumer channels and durable medical equipment providers, with offerings intended for use in homes and other non-hospital settings.

Founded in 2001 and headquartered in Goleta, California, Inogen serves customers in the United States and select international markets. The company’s products are used by individuals who require long-term oxygen therapy, including patients with chronic obstructive pulmonary disease and other respiratory disorders.

View Inogen Profile
Earnings Tools